NCT05990400

Effectiveness and Safety of Topical Finasteride and Minoxidil Combination Compared to Topical Minoxidil for The Treatment of Male Androgenetic Alopecia

• Status: Unknown
• Phase: Phase 2 / Phase 3
• Study type: Interventional
• Enrollment: 40 (estimated)
• Sponsor: Indonesia University · Academic / Other
• Sex: Male
• Age: 18 Years – 59 Years
• Healthy volunteers: Accepted

Summary

A double-blind, randomized, controlled trial of 40 male patients with androgenetic alopecia was conducted. All subject were randomized to receive either combination of minoxidil 5% topical and finasteride 0,1% topical or minoxidil 5% topical

Detailed description

All subject were randomized to receive either combination of minoxidil 5% topical and finasteride 0,1% topical or minoxidil 5% topical The primary outcome was increase of the hair density and hair diameter (mean thickness) measured by trichoscan Measurements were done at baseline and every four weeks for twelve weeks. Additionally, side effects of therapy was also measured.

Conditions

• Androgenetic Alopecia

Interventions

Type	Name	Description
DRUG	Finasteride	finasteride topical 0,1%
DRUG	Minoxidil	minoxidil topical 5%

Timeline

• Start date: 2023-05-01
• Primary completion: 2023-10-30
• Completion: 2023-12-30
• First posted: 2023-08-14
• Last updated: 2023-09-22

Locations

1 site across 1 country: Indonesia